Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan;102(1):115565.
doi: 10.1016/j.diagmicrobio.2021.115565. Epub 2021 Oct 2.

SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies

Affiliations
Case Reports

SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies

Enagnon Kazali Alidjinou et al. Diagn Microbiol Infect Dis. 2022 Jan.

Abstract

SARS-CoV-2 infections after COVID-19 vaccination are not unexpected, but those occurring more than 14 days after second vaccine dose need to be investigated. We describe a well-characterized infection which occurred almost 2 months after full vaccination, and provide the evidence of a link with a lack of anti-SARS-CoV-2 neutralizing antibodies.

Keywords: COVID-19; Infection; Neutralizing antibodies; SARS-CoV-2; Vaccination.

PubMed Disclaimer

References

    1. Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021 doi: 10.1056/NEJMoa2109072. - DOI - PMC - PubMed
    1. Boehm E, Kronig I, Neher RA, Eckerle I, Vetter P, Kaiser L, et al. Novel SARS-CoV-2 variants: the pandemics within the pandemic. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27:1109–1117. doi: 10.1016/j.cmi.2021.05.022. - DOI - PMC - PubMed
    1. Charmet T, Schaeffer L, Grant R, Galmiche S, Chény O, Von Platen C, et al. Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: results from a nationwide case-control study in France. Lancet Reg Health - Eur. 2021;8 doi: 10.1016/j.lanepe.2021.100171. - DOI - PMC - PubMed
    1. Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412–1423. doi: 10.1056/NEJMoa2101765. - DOI - PMC - PubMed
    1. Keehner J, Horton LE, Pfeffer MA, Longhurst CA, Schooley RT, Currier JS, et al. SARS-CoV-2 infection after vaccination in health care workers in California. N Engl J Med. 2021;384:1774–1775. doi: 10.1056/NEJMc2101927. - DOI - PMC - PubMed

Publication types